Literature DB >> 120550

Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy.

M J Dillon, V Shah, M D Mitchell.   

Abstract

Ten children with Bartter's syndrome are described. Their ages at diagnosis ranged from three months to 15 years and there was an equal sex distribution. A wide spectrum of severity of clinical and biochemical features was found. Hypercalcaemia, hypophosphataemia, hypercalcuria, nephrocalcinosis, rickets and urine acidification defects were seen in some patients. Two affected children were siblings. Six children were treated over periods of six to 24 months with indomethacin with remarkable clinical and biochemical improvement. Catch-up growth was demonstrated in all treated cases. Tolerance to indomethacin appeared to develop in some children. Only one serious complication was seen with this therapy, a duodenal ulcer in a child on high dosage. Of those children not treated with indomethacin, one died, one is now on indomethacin elsewhere and two are well without therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 120550

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  13 in total

1.  Pseudo-Bartter's syndrome in cystic fibrosis.

Authors:  J D Kennedy; R Dinwiddie; C Daman-Willems; M J Dillon; D J Matthew
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

2.  Bartter's syndrome, nephrocalcinosis and renal insufficiency.

Authors:  A Pierratos; R A Couture; P J Hierlihy; R C Bell; D Z Levine
Journal:  CMAJ       Date:  1989-11-15       Impact factor: 8.262

Review 3.  Threading through the mizmaze of Bartter syndrome.

Authors:  Willem Proesmans
Journal:  Pediatr Nephrol       Date:  2006-05-16       Impact factor: 3.714

Review 4.  Salt-Losing Tubulopathies in Children: What's New, What's Controversial?

Authors:  Robert Kleta; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2017-12-13       Impact factor: 10.121

5.  Pre-pubertal growth in the hyperprostaglandin E syndrome.

Authors:  C Seidel; S Reinalter; H W Seyberth; K Schärer
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

6.  Dose related growth response to indometacin in Gitelman syndrome.

Authors:  L C Liaw; K Banerjee; M G Coulthard
Journal:  Arch Dis Child       Date:  1999-12       Impact factor: 3.791

7.  Bartter syndrome: benefits and side effects of long-term treatment.

Authors:  Maria Helena Vaisbich; Maria Danisi Fujimura; Vera H Koch
Journal:  Pediatr Nephrol       Date:  2004-06-16       Impact factor: 3.714

8.  Renin-angiotensin-aldosterone system.

Authors:  M J Dillon
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

9.  Nephrocalcinosis in Bartter's syndrome.

Authors:  L Garel; D Filiatrault; P Robitaille
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

10.  Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome.

Authors:  W Proesmans; G Massa; M Vanderschueren-Lodeweyckx
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.